본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma. 박중원
(임상의학연구부)
박중원:김보현:김진숙, 이숙경, 홍은경. Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma. GUT AND LIVER. 2019-05-15; 2018; 13(3):342~348. IF 2.849 (2017)
김보현
(간담도췌장암센터)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma 박중원
(임상의학연구부)
박중원, KLCA::. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma GUT AND LIVER. 2019-05-15; 2019; 13(3):227~299. IF 2.968 (2018)

Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer 안한종(울산대)
안한종(울산대):박사현:. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2019-05-13; 2019; Online:Published. IF 2.503 (2018)
박사현
(비뇨기암센터)
Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities 송기훈
(피부과)
송기훈:T. H. Kim(동아대):. Efficacy and clinical significance of omitting blue dye injection during sentinel lymph node biopsy before Mohs micrographic surgery for malignant melanoma of the lower extremities BRITISH JOURNAL OF DERMATOLOGY. 2019-05-11; 2019; Online:Published. IF 6.714 (2018)
T. H. Kim(동아대)
Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer 박상윤
(자궁난소암센터)
박상윤:유헌종(충남대):임명철, 서상수, 강석범, 주정남. Phase I/II clinical trial of modulated electro-hyperthermia treatment in patients with relapsed, refractory or progressive heavily treated ovarian cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY. 2019-05-09; 2019; Online:Published. IF 2.183 (2018)
유헌종(충남대)
Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer 손대경
(융합기술연구부)
손대경:오지은:이주형, 김민주, 허보윤, 김번, 김대용, 백지연, 장희진, 박성찬, 오재환, 조선아. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer CANCER RESEARCH AND TREATMENT. 2019-05-07; 2019; Online:Published. IF 3.363 (2018)
오지은
(융합기술연구부)
Getting patient blood management Pillar 1 right in the Asia-Pacific: a call for action Bernd Froessler(McEwin Hospital)
Bernd Froessler(McEwin Hospital):Abdullah HR, Ang AL, Froessler B, Hofmann A, Jang JH, Lasocki S, Lee JJ, Lee SY, Lim KKC, Singh G, Spahn DR, Um TH(외부), 김영우(내부):. Getting patient blood management Pillar 1 right in the Asia-Pacific: a call for action Singapore Medical Journal. 2019-05-02; 2019; Online:Published. IF 1.141 (2018)
김영우
(암관리학과)
Employment conditions and use of gastric cancer screening services in Korea: a nationwide survey 신지연(경북대)
신지연(경북대):전재관,심혜영(을지대):. Employment conditions and use of gastric cancer screening services in Korea: a nationwide survey BMC Public Health. 2019-05-02; 2019; 19(1):485~485. IF 2.567 (2018)
전재관
(암예방검진부)
Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study 김충수(아산병원)
김충수(아산병원):정재영, 권휘안(명지병원):김성한, 이강현, 이정은, 서호경. Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study invesitgative and clinical urology. 2019-05-01; 2019; 60(3):195~201. IF 1.638 (2018)
정재영
(비뇨의학과)
Upregulation of transforming growth factor-beta type I receptor by interferon consensus sequence-binding protein in osteosarcoma cells 김용연
(이행성연구부)
박병규
(임상의학연구부)
박병규, 김용연:성지영, 윤경실:고성호, 김준혁, 강현귀, 박석연. Upregulation of transforming growth factor-beta type I receptor by interferon consensus sequence-binding protein in osteosarcoma cells Biochimica et Biophysica Acta(BBA)-Molecular Cell Research. 2019-05-01; 2019; 1866(5):761~772. IF 4.739 (2018)
윤경실
(이행성연구부)
성지영
(희귀난치암연구과)